Navigation Links
Informex Introduces a Thorough Global Pharma Perspectives Conference
Date:10/26/2011

PRINCETON, N.J., Oct. 26, 2011 /PRNewswire/ -- Informex, the leading meeting place for buyers and sellers of high-value chemistry, today announced details of the Global Pharma Sourcing Conference to be held December 6-7, 2011 at the Hilton Philadelphia City Avenue in Philadelphia, Pennsylvania. The two day program will be jointly hosted by UBM Live brands Informex and CPhI to address key issues that global chemical and pharmaceutical industry players are facing in the changing market. Featured presentations over the two days will provide information about risk management, global sourcing, supply chain and anti-counterfeiting strategies. Other topics will include the protection of intellectual property, due diligence and the challenges and opportunities of working with India, China and other regions. The Conference presentations will be made by high-level speakers from firms including SAFC, Eli Lilly, Aptuit, PwC, Teva, Arch and Catalent.

"A key factor in staying ahead in any industry is to constantly keep an eye on what is ahead. In the changing chemical and pharmaceutical industries, it is important for companies to identify how to move with the trends and risks associated with global sourcing," said Jennifer Jessup, Global Brand Director, Informex. "The Global Pharma Sourcing Conference is an exciting expansion of our portfolio and will allow us to address customer needs for identifying strategies to succeed in today's market."

Each day will begin with a keynote speech and move forward into the presentation format.  The keynote on day one will cover how to derive a sustainable business advantage from a global sourcing strategy. Day two will begin with a keynote speech about managing the supplier relationship and will provide solutions for developing a global strategy.  The program will be complemented by breakfast, lunch and daytime networking opportunities that will offer time to connect and share
'/>"/>

SOURCE Informex
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Informex Opens Registration to InformexUSA 2009
2. InformexUSA 2009 Opens to Strong Attendance
3. Informex Survey Shows Innovation Remains a Priority for 2009 and Beyond
4. Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees
5. Inaugural Pharma Exchange Conference Produced by Informex to Draw Together Milwaukee, Wisconsin Chemical Industry
6. LI-COR August 27th On-Line Webinar Introduces New Approach to Small Animal In Vivo Imaging
7. LUMEDX Introduces Advanced Multi-Modality, Multi-Vendor, Web-Enabled ECG Management Solution
8. McGraw-Hill Higher Education Introduces New Introductory Level Biology Content
9. Bruker Introduces HyperQuant™, a Unique Bench-Top NMR Reader to Quantify Hyperpolarization
10. OmniGuide Introduces The BeamPath Neuro(TM): A CO2 Laser Fiber for Brain And Spine Surgery
11. Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending PCT Shredder at the Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... studies for its newly developed Bruton,s tyrosine kinase ... been completed. The results of these preclinical evaluations ... Drug Administration. The feedback received from the Agency ... first-in-human study. Additional preclinical work is required to ...
(Date:2/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has ... Trypsin" report to their offering. , ... comprehensive data on Trypsin globally and regionally ( Europe ... America , Latin America etc.). ... This report focuses on three primary areas; manufacture ...
(Date:2/27/2015)... 27, 2015 The fully automated ... UC) can sequentially analyze up to 48 samples ... high-sensitivity detection of targets by mass spectrometry. ... fulfill the measurement requirements of a wide range ... drug delivery and search for disease biomarkers, additives ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Global Market Report of Trypsin 2014-2018 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3
... Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ... Scientific Corporation (NYSE: BSX ) has ... with left main coronary disease who were treated ... SYNTAX-LE MANS is a substudy of the landmark ...
... ( http://www.gene2drug.com ) -- the ... science industry -- announces the publication of its latest ... for Commercial Suppliers, Vol. III." Given the highly ... report is designed to create opportunities for differentiation by ...
... Cholesterol Test for determining heart disease riskBIRMINGHAM, Ala., May ... developer of the VAP Cholesterol Test, has announced it ... and report apolipoprotein B100 (apoB) using the Vertical Auto ... of the VAP Cholesterol Test to accurately report apoB, ...
Cached Biology Technology:SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 2SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 3SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 4SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 5BioInformatics, LLC New Report -- The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III 2Atherotech Receives Patent for ApoB Measurement 2Atherotech Receives Patent for ApoB Measurement 3
(Date:2/13/2015)... TAIPEI , Feb. 13, 2015 ... service company that aims to transform cancer genomic ... announced that the company has raised US$ 8 million ... Based in Taipei, Taiwan ... tests, ACTDrug™, ACTOnco™. With the aim to implement ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... PITTSBURGH, Oct. 23 A new study suggests that viruses ... cells while promoting the growth of surviving cells with cancerous ... wiping out normal cells that support the replication of viruses ... their circuitry. When this process is repeated over and over, ...
... David Jones, a fisheries oceanographer at the Cooperative Institute for ... Miamis Rosenstiel School, set out to design a better light ... invention would contribute to the discovery of a new species. ... known description, his catch turned out to be the answer ...
... Captains Log originally used with individuals diagnosed ... learning disabilities is being adapted to rehabilitate ... Michael Boivin, a Michigan State University associate ... and Bruno Giordani, a University of Michigan associate ...
Cached Biology News:Study proposes new theory of how viruses may contribute to cancer 2New light trap captures larval stage of new species; DNA barcode technology used 2MSU researcher helps develop computer game for Ugandan children recovering from cerebral malaria 2
...
Borrelia Burgdorfen (IgG) -Ab EIA Sample Size: 100 l...
... is a protein ribonuclease inhibitor that noncovalently binds ... inhibition is seen with RNase 1, T1, T2, ... from human placental ribonuclease inhibitor in that it ... does not release active RNase in the absence ...
... Inkjet Printer) is a revolutionary new ... Protein Macroarray Analysis, developed in conjunction ... strategy compliments established protocols in resolving ... proteins isoelectric point and apparent molecular ...
Biology Products: